TITLE

Icahn calling off Mylan war?

PUB. DATE
April 2014
SOURCE
Fierce Finance IT;4/19/2014, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
95700798

 

Related Articles

  • ICAHN THE SPOILER. Creswell, Julie // Fortune;3/21/2005, Vol. 151 Issue 6, p195 

    Profiles financier Carl Icahn. Description of Icahn's purchase of shares in Mylan Laboratories after a fall in their stock prices; Efforts of Icahn to prevent a merger between Mylan and King Pharmaceuticals; Description of relations between Mylan and King, and the characteristics of the...

  • FOR ICAHN, BREAKING UP IS HARD TO DO. Creswell, Julie // Fortune;1/24/2005, Vol. 151 Issue 2, p26 

    Discusses the efforts of financier Carl Icahn to break up the deal between drugmaker Mylan Laboratories and King Pharmaceuticals. Description of Icahn's purchase of stake in Mylan and struggles in his attempt to block the deal; How Icahn's reaction to the deal demonstrates a shift in his...

  • Mylan Faces Battle with Carl Icahn.  // Chemical Market Reporter;9/13/2004, Vol. 266 Issue 8, p3 

    Reports on the battle between Mylan Laboratories and corporate financier Carl Icahn over the proposed multi-dollar acquisition of King Pharmaceuticals Inc. Shares of Icahn group in Mylan Laboratories; Intentions of Icahn on the acquisition; Long-term interest of the plan for shareholders.

  • Mylan, Icahn battle over planned acquisition.  // Drug Store News;1/17/2005, Vol. 27 Issue 1, p24 

    Reports on the dispute over Mylan Laboratories' bid to acquire King Pharmaceuticals in the U.S. Opposition of largest shareholder Carl Icahn to the planned acquisition; Response of Mylan to the lawsuit filed by an investment company Icahn controls; Consideration of generic competition from...

  • INDUSTRY WEIGHS ICAHN MOTIVE FOR PENNEY'S STAKE. Edelson, Sharon // WWD: Women's Wear Daily;2/4/2008, Vol. 195 Issue 25, p38 

    The article speculates on the plans of investor Carl Icahn for J.C. Penney. There has been speculation that Icahn will call for Penney's to repurchase stock or sell off real estate. Icahn has not been a fan of Penney's aggressive expansion plans, but the retailer's chairman and chief executive...

  • INVESTMENT BANKING DATABASE: HEALTHCARE.  // Investment Dealers' Digest;2/28/2005, Vol. 71 Issue 8, p40 

    The article presents information on the recent developments related to investment banking in the healthcare sector. Carl Icahn, who owns a 9.8% stake in Mylan Laboratories Inc., sued the genetic drug maker to block recently amended corporate bylaws announced by the company calling for director...

  • EBay Split Divides Investors. Investor's Business Daily // Investors Business Daily;3/13/2014, pA01 

    6 Investors and analysts are split on activist Carl Icahn's call for eBay ([STOCK[EBAY]]) to spin off its lucrative PayPal online payments unit. Icahn proposed this 2 months ago after taking a 1% stake in eBay. A Bernstein report says 55% of investors polled favor changing eBay's board, but just...

  • Icahn targets TW board ; and maybe even Parsons. Zeitchik, Steven // Daily Variety;11/21/2005, Vol. 289 Issue 37, p4 

    Reports on the plan of Carl Icahn to remove board members at Time Warner Inc. Claim of Icahn that his investor group are forming a slate of proposed directors to replace some or all of the board; Move of Icahn to call for changes at the company; Criticism of Icahn of the management of the company.

  • Wrong time, wrong place.  // Aviation Week & Space Technology;10/21/1991, Vol. 135 Issue 16, p7 

    Editorial. Argues that Trans World Airlines Chairman Carl Icahn's unusual fare-cutting plan called the Business Saver Program is poorly timed for an airline preparing to reorganize under the bankruptcy code. Handling of the announcement; Avoiding a protracted fare war.

  • Generic Capsules.  // Pharmacy Today;Jan2005, Vol. 11 Issue 1, p20 

    The article presents news related to generic capsules. It states that generic cholesterol drugs and branded cholesterol drugs are equally effective. Generic drugmaker Mylan Inc.'s largest shareholder, Carl Icahn has challenged the acquisition of King Pharmaceuticals Inc. by Mylan. Four generic...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics